Valencia Biofoundry
Collaborative platform to drive bioproduction and innovation in the Valencian Community.
What is Valencia Biofoundry?
Valencia Biofoundry is a network of Valencian entities with an interest in developing and offering shared capabilities in synthetic biology and bioproduction. This platform aims to provide integrated infrastructure to other companies or entities through rapid prototyping of cell factories based on Industry 5.0 principles, including highly automated laboratory equipment integration, device interoperability and the use of artificial intelligence.
Valencia Biofoundry is a collaborative platform focused on advanced bioproduction, connecting scientific talent, infrastructure and innovative projects to drive biotechnology in the Valencian Community.
Infrastructure
Access to facilities, equipment and technical capabilities for the development of bioproduction projects.
Collaboration
Connection between research centres, companies and professionals in the biotechnology sector.
Innovation
Support for innovative projects with high potential for transfer and industrial application.
Who we are
I²SYSBio focuses on the study of the structure, function, dynamics, evolution, and engineering of complex biological systems. The institute stands out for its expertise in automating bioproduction processes in microbial and cellular factories, integrating metabolic engineering, synthetic biology, and advanced systems biology approaches to develop innovative biotechnological solutions.
IBMCP is an internationally recognised centre for plant research, with outstanding capabilities in plant synthetic biology and plant biofactories. They are noted for their expertise in the design and assembly of synthetic genetic circuits, the use of advanced genome editing technologies and the development of plant platforms for the production of recombinant proteins of industrial and therapeutic interest.
IATA is an international reference in agri-food research. Its focus on yeast metabolism in wine fermentation, especially under low temperature conditions, and its expertise in industrial microbiology bioprocesses represent a key contribution to the development of advanced biotechnological solutions.
AINIA is a technology centre with over 35 years of experience in R&D&I, offering companies innovation, technology and consultancy services in sectors such as agriculture, food, cosmetics, chemicals, environment and pharmaceuticals. With facilities of over 13,000 m², they have state-of-the-art infrastructure and equipment for R&D.
INESCOP is an innovation and technology centre with 50 years of experience, providing technological services, transferring knowledge and researching topics of general interest to the footwear sector. Its main objective is to promote innovation in the footwear sector, offering solutions to meet the scientific and technical needs of companies.
PERSEO Biotechnology develops solutions for the valorization of organic waste and by-products, transforming them into advanced bioethanol, bioproducts, and bioenergy. Using proprietary technology, the company designs and implements industrial processes based on circular economy principles, generating high-value products from underutilized resources
Madeinplant is an agrobiotechnology company dedicated to the production of high added-value biomolecules in plants and the development of biotechnological tools for commercially valuable processes in sectors such as agri-food, cosmetics and pharmaceuticals.
Bioinicia develops and manufactures nanostructured materials using electrospinning and electrospray technologies. The company has extensive experience in the pharmaceutical, cosmetic, food, and medical device sectors, as well as in advanced formulations, biomolecule encapsulation, and the industrial scale-up of production processes.
ADM Biopolis is a biotechnology company founded in 2003, with the primary objective of transferring quality science to the agri-food, chemical and pharmaceutical industries. It offers contract research and production services to the agri-food, chemical and pharmaceutical industries to improve their competitive position and advantages.
Bionanopharma is a joint venture between the Bioinicia Group, a spin-off of IATA-CSIC, and InSud Pharma, dedicated to the development and commercialization of nanotechnology-based pharmaceutical and biomedical products. The company combines formulation, development, and scale-up capabilities to drive innovative therapeutic solutions.
Ajax DNA facilitates bioproduction, particularly during the discovery and development phases of new molecules. The company stands out for its in vivo DNA synthesis technologies, Lab-on-a-Cell platforms, and artificial intelligence and digital twin tools for microbial consortium optimization and DNA design applied to bioprocesses.
